Syngenta Group reported October 30 that sales for the first nine months of 2026 fell 5% to $17.3 billion, while EBITDA increased 1% to approximately $3.2 billion.
Its EBITDA margin widened to 18.4% from 17.4%. EBITDA is a supplemental, non-GAAP earnings measure and is distinct from net income.
The company attributed part of the sales decline to its planned withdrawal from grain trading and other lower-margin activities. Excluding those reductions, it reported 1% underlying sales growth.
The third quarter was weaker: sales declined 10% to $5.2 billion, while EBITDA fell 2% to about $800 million. Syngenta cited delayed purchases in some markets alongside the portfolio changes.
North American seeds sales fell 11% over nine months. The company attributed that decline to restructuring and fewer U.S. corn acres planted across the industry. North American crop-protection sales declined 1%.
Prior-year comparisons were restated following the removal of Sinofert from consolidation.
Image: Company promotional footage; recording date and location were not specified.
Sources: Syngenta Group — October 30 Results via Business Wire: https://www.businesswire.com/news/home/20261030437620/en/ Image source — Syngenta Group Promotional Video, Frame 00:03.000; Recording Date Unspecified: https://www.syngentagroup.com